Search

The collection of single‐photon emission from a quantum dot (QD) in a Bragg waveguide through a photonic wire bond (PWB) via free‐space resonant frequency pumping at 1.6 K is demonstrated. The in‐fiber single photons show a small multiphoton contribution, quantified by a low second order photon autocorrelation value of gcorr(2)(0)=(5.9±0.8)×10−3$g_{{\mathrm{corr}}}^{(2)}\;(0) = ({5.9 \pm 0.8})\; \times {10^{ - 3}}$ (background‐corrected) or graw(2)(0)=(9.5±1.4)×10−2$g_{{\mathrm{raw}}}^{(2)}(0)\; = ({9.5 \pm 1.4})\; \times {10^{ - 2}}{\mathrm{\;}}$(raw data). The decay time of the QD is measured to be τ=440${\mathrm{\tau \;}} = {\mathrm{\;}}440$ ps. The PWB obviates the need for in‐cryostat alignment of the single‐photon source with an optical fiber and thus offers a route to scalable integration of quantum photonic devices in a cryogenic environment. Uniquely, the approach combines the QD‐waveguide technique, enabling resonant driving of individual QDs without the need for cross‐polarization filtering, and the PWB for deterministic, alignment‐free coupling of single‐photon sources to optical fibers. [ABSTRACT FROM AUTHOR]

Objective: A handheld device was developed and qualified for in vivo human skin evaluation using laser speckle imaging technology. Methods: Each laser speckle device prototype allows the choice of up to three different laser wavelengths in the range of 400 nm to 800 nm in total. Speckle pattern analysis gives various speckle parameters, for example, speckle contrast, speckle size, speckle modulation or fractal dimension. The developed laser speckle device prototypes were evaluated investigating three skin issues. Results: We receive reproducible results from the speckle imaging device. For skin ageing, we found significant changes within three age groups. The effect of a methyl nicotinate treatment was clearly visible and quantifiable using a moorFLPI device as well as our speckle imaging device. In terms of basal cell carcinoma diagnosis, we found significant differences between normal and diseased skin, even though the number of samples was limited. Conclusion: As shown with first application examples, it was possible to demonstrate the potential of the method for skin evaluation in vivo. [ABSTRACT FROM AUTHOR]

Objective: A mobile handheld snapshot hyperspectral imaging device was developed and tested for in vivo skin evaluation using a new spectral imaging technology. Methods: The device is equipped with four different LED light sources (VIS, 810 nm, 850 nm, and 940 nm) for illumination. Based on a diffractive optical element (DOE) combined with a CMOS sensor chip, a snapshot hyperspectral imager is achieved for the application on human skin. The diffractive optical element (DOE) consists of a two‐dimensional array of identically repeated diffractive microstructures. One hyperspectral image for all wavelength regions is taken within a few seconds. Complex recalculation of the VIS spectral distribution and image information from the received DOE image requires several minutes, depending on computing performance. A risk assessment on the irradiation sources shows no risk of harm due to the LED radiation. Results: Skin tone color patches experiments reproducibly deliver images and spectra of different skin tones. First in vivo use of the device identified pigmentation changes within the field of view. Conclusion: We present a working mobile snapshot hyperspectral imaging tool based on diffractive optical elements. This device or future developments thereof can be used for broad skin evaluation in vivo. [ABSTRACT FROM AUTHOR]